Malaria Diagnostics Market Analysis of RDTs, Microscopy, and Regional Trends

The global malaria diagnostics market was valued at USD 759.1 million in 2023 and is projected to reach USD 900.5 million by 2030, growing at a CAGR of 2.6% from 2024 to 2030. Market growth is being driven by the rising need for accurate malaria detection and the introduction of innovative diagnostic technologies.

Malaria remains a widespread and life-threatening disease, particularly in tropical and subtropical regions. Its prevalence is influenced by factors such as shifting climate conditions, limited economic development, inadequate healthcare infrastructure, and insufficient access to advanced medical treatment.

Major technological advancements have significantly enhanced malaria diagnostics in recent years. Modern molecular testing methods—including Loop-Mediated Isothermal Amplification (LAMP) and nucleic acid amplification tests (NAATs)—deliver higher sensitivity and specificity than traditional diagnostic approaches. In addition, the continued evolution of rapid diagnostic tests (RDTs) has improved point-of-care detection by offering fast, accurate parasite identification. These innovations have transformed the speed and precision of malaria diagnosis, enabling timely treatment and effective disease management, especially in resource-limited environments where access to fully equipped laboratories is often constrained.

Key Market Trends & Insights

• Africa dominated the market with an 89.15% share in 2023.
• By technology, Rapid Diagnostic Tests (RDTs) led the market in 2023, accounting for 67.8% of revenue.
• By end use, clinics represented the largest market segment, with a 64.4% share in 2023.

Download a free sample PDF of the Malaria Diagnostics Market Intelligence Study by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 759.1 Million
• 2030 Projected Market Size: USD 900.5 Million
• CAGR (2024–2030): 2.6%
• Largest Regional Market (2023): Africa

Competitive Landscape

Competition in the malaria diagnostics market is strong, with major players such as Abbott, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, and Bio-Rad Laboratories, Inc. holding significant market positions. Leading companies are focusing on strategies such as geographic expansion, acquisitions, mergers, product innovation, and strategic collaborations to address unmet diagnostic needs and strengthen their market presence.

Prominent Companies

• Access Bio., Inc.
• Abbott Laboratories
• Premier Medical Corporation Pvt. Ltd.
• Sysmex Partec GmbH
• bioMérieux
• Beckman Coulter, Inc.
• Siemens Healthineers
• Leica Microsystems GmbH
• Nikon Corporation
• Olympus Corporation
• Bio-Rad Laboratories, Inc.

Explore Horizon Databook – the world’s most comprehensive market intelligence platform by Grand View Research.

Conclusion

The malaria diagnostics market is poised for steady growth, supported by advancements in molecular testing technologies and improved rapid diagnostic capabilities. As innovation continues and access to efficient diagnostic tools expands—particularly in high-burden regions—the market will play a critical role in global malaria control and prevention efforts.